🔥Telegram İfşa

ZEB2 controls kidney stromal progenitor differentiation and inhibits abnormal myofibroblast expansion and kidney fibrosis: buff.ly/3IU5fyv Weining (Wein) Lu Boston Medical Center #Development #Nephrology

Lu Lab mini reunion today American Society of Nephrology #KidneyWk. Great oral presentation from Sudhir Kumar BU/BMC Section of Nephrology and a poster from former Boston U Chobanian & Avedisian School of Medicine BU Graduate Medical Sciences GPGG PhD student Hila Milo Rasouly, who is now a faculty and leader in renal genetics implementation @ColumbiaKidney

Thank you to my mentor, Dr. Weining (Wein) Lu and members of my mentoring team for their support! Thank you AHA Research for this Award!

Thank you, Dr. Lu Weining (Wein) Lu!

Two great talks in one afternoon Boston Medical Center & Boston U Chobanian & Avedisian School of Medicine by Laurence H Beck, Jr of BU/BMC Section of Nephrology on #IgAN, an #autoimmune disease, followed by Wilson Wong of Boston University Biomedical Engineering BU Engineering on #CART therapy for #autoimmune disease. #Science transnational #research connected both 👏

Excellent talk from Dr. Sudhir Kumar of BU/BMC Section of Nephrology in San Diego #kidneyweek2024 American Society of Nephrology annual meeting today on ZEB2 in determining #cellfate of #kidney stroma progenitor cells during #KidneyDevelopment. Sudhir Kumar

ZEB2 signaling is essential for ureteral smooth muscle cell differentiation and maintenance biorxiv.org/content/10.110… #biorxiv_devbio

ZEB2 and #ureter development Weining (Wein) Lu biorxiv.org/content/10.110…